Sagar Lonial Discusses Treating Patients With Myeloma

Article

Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.

Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.

Lonial says that care should be directed by a myeloma expert who can define a treatment plan over the next 6 to 12 months.

While new treatment options for myeloma have recently emerged, Lonial says it’s important for providers to know when to treat and when not treat with a new drug. He adds that patients should be encouraged to admit any adverse events, particularly neuropathy or fatigue, which can impact quality of life.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
Related Content